Securities and Exchange Commission v. Nutra Pharma Corporation et al
Case Number:
2:18-cv-05459
Court:
Nature of Suit:
Judge:
Firms
Government Agencies
-
March 15, 2024
'Cobra Venom' Painkiller Co. Inks Deal To Settle SEC Claims
A penny stock company that previously held itself out as a maker of cobra venom-infused pain drugs has agreed to resolve U.S. Securities and Exchange Commission fraud claims, according to court filings that note the company's two principals have also reached a settlement.
-
April 01, 2020
Promoter Disclosed 'Cobra Venom' Co. Payment, Judge Says
A federal judge in New York on Tuesday trimmed allegations concerning a pay-for-play stock promoter from a suit alleging a Florida company misrepresented that it made cobra venom pain relievers.
-
September 28, 2018
SEC Accuses Drugmaker of Venomous Deceptions
A Florida-based microcap securities issuer that claimed to make pain relievers with cobra venom is accused by the U.S. Securities and Exchange Commission in a civil complaint filed Friday of misleading investors by claiming, among other things, that it was distributing its product internationally when it was not.